Recent Updates
Recently added Catalysts
JNJ

Johnson & Johnson to Participate in the Goldman Sachs 37th Annual Global Healthcare Conference Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 37th Annual Global Healthcare Conference on Wednesday, June 8, at the Terranea in ...

Key Takeaway: NEW BRUNSWICK, N.J. , May 25, 2016 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the Goldman Sachs 37th Annual Global Healthcare Conference on Wednesday, June 8 , at the Terranea in Rancho Palos Verdes, CA. Dominic Caruso, Executive Vice President, Chief Fina

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2

Full Press Release Details

NEW BRUNSWICK, N.J. , May 25, 2016 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the Goldman Sachs 37th Annual Global Healthcare Conference on Wednesday, June 8 , at the Terranea in Rancho Palos Verdes, CA. Dominic Caruso, Executive Vice President, Chief Financial Officer will represent the Company in a session scheduled at 9:20 a.m. (Pacific Time) .
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast and podcast replay will be available approximately two hours after the live webcast.
Last updated: May 25, 2016